Free Trial

Trading of Nanovibronix was halted at 10:42 AM EST due to "LULD pause".

Nanovibronix (NAOV) Competitors

Nanovibronix logo
$10.70 +4.21 (+64.87%)
Closing price 04:00 PM Eastern
Extended Trading
$9.83 -0.87 (-8.17%)
As of 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

NAOV vs. IINN, SINT, NVNO, NXL, INBS, OSRH, FEMY, CODX, MHUA, and DHAI

Should you be buying Nanovibronix stock or one of its competitors? The main competitors of Nanovibronix include Inspira Technologies OXY B.H.N. (IINN), Sintx Technologies (SINT), enVVeno Medical (NVNO), Nexalin Technology (NXL), Intelligent Bio Solutions (INBS), OSR (OSRH), Femasys (FEMY), Co-Diagnostics (CODX), Meihua International Medical Technologies (MHUA), and DIH Holding US (DHAI). These companies are all part of the "medical equipment" industry.

Nanovibronix vs. Its Competitors

Nanovibronix (NASDAQ:NAOV) and Inspira Technologies OXY B.H.N. (NASDAQ:IINN) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, dividends, risk, valuation, analyst recommendations, profitability, media sentiment and earnings.

Nanovibronix has higher revenue and earnings than Inspira Technologies OXY B.H.N..

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Nanovibronix$2.56M3.34-$3.70M-$13.53-0.79
Inspira Technologies OXY B.H.N.N/AN/A-$11.05MN/AN/A

Inspira Technologies OXY B.H.N. has a net margin of 0.00% compared to Nanovibronix's net margin of -380.29%. Inspira Technologies OXY B.H.N.'s return on equity of 0.00% beat Nanovibronix's return on equity.

Company Net Margins Return on Equity Return on Assets
Nanovibronix-380.29% -45.24% -34.24%
Inspira Technologies OXY B.H.N. N/A N/A N/A

In the previous week, Nanovibronix had 5 more articles in the media than Inspira Technologies OXY B.H.N.. MarketBeat recorded 10 mentions for Nanovibronix and 5 mentions for Inspira Technologies OXY B.H.N.. Nanovibronix's average media sentiment score of 1.45 beat Inspira Technologies OXY B.H.N.'s score of 0.58 indicating that Nanovibronix is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Nanovibronix
1 Very Positive mention(s)
2 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Inspira Technologies OXY B.H.N.
1 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Nanovibronix has a beta of 2.1, indicating that its share price is 110% more volatile than the S&P 500. Comparatively, Inspira Technologies OXY B.H.N. has a beta of 2.29, indicating that its share price is 129% more volatile than the S&P 500.

Inspira Technologies OXY B.H.N. has a consensus price target of $2.00, indicating a potential upside of 70.94%. Given Inspira Technologies OXY B.H.N.'s stronger consensus rating and higher possible upside, analysts clearly believe Inspira Technologies OXY B.H.N. is more favorable than Nanovibronix.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Nanovibronix
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Inspira Technologies OXY B.H.N.
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

16.4% of Nanovibronix shares are owned by institutional investors. Comparatively, 12.7% of Inspira Technologies OXY B.H.N. shares are owned by institutional investors. 6.3% of Nanovibronix shares are owned by company insiders. Comparatively, 29.4% of Inspira Technologies OXY B.H.N. shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Summary

Inspira Technologies OXY B.H.N. beats Nanovibronix on 8 of the 13 factors compared between the two stocks.

Get Nanovibronix News Delivered to You Automatically

Sign up to receive the latest news and ratings for NAOV and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding NAOV and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

NAOV vs. The Competition

MetricNanovibronixMED INSTRUMENTS IndustryMedical SectorNASDAQ Exchange
Market Cap$5.17M$6.70B$5.75B$10.24B
Dividend YieldN/A1.20%5.69%4.60%
P/E RatioN/A25.8474.9326.41
Price / Sales3.34173.22452.3586.56
Price / CashN/A22.1825.8129.91
Price / Book0.584.9413.256.28
Net Income-$3.70M$176.38M$3.29B$270.38M
7 Day Performance100.37%4.95%0.47%2.70%
1 Month Performance82.59%6.43%4.60%5.99%
1 Year Performance-85.90%10.59%73.42%25.94%

Nanovibronix Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NAOV
Nanovibronix
1.2918 of 5 stars
$10.70
+64.9%
N/A-91.4%$5.17M$2.56M-0.7920News Coverage
Positive News
Short Interest ↓
Gap Up
Trading Halted
High Trading Volume
IINN
Inspira Technologies OXY B.H.N.
1.7702 of 5 stars
$1.20
-0.8%
$2.00
+66.7%
+0.0%$15.27MN/A0.0020Short Interest ↑
SINT
Sintx Technologies
1.9785 of 5 stars
$4.59
-16.7%
$28.00
+510.0%
+6.9%$15.20M$2.89M-0.0940Gap Down
NVNO
enVVeno Medical
0.6134 of 5 stars
$0.76
-1.8%
N/A-85.5%$14.88MN/A-0.6330News Coverage
Short Interest ↑
Gap Up
NXL
Nexalin Technology
2.1446 of 5 stars
$0.83
-0.7%
$5.00
+502.0%
+30.7%$14.56M$170K-1.093
INBS
Intelligent Bio Solutions
0.6807 of 5 stars
$1.64
+5.8%
N/A-10.5%$13.92M$3.05M-0.8010News Coverage
Positive News
Analyst Upgrade
Gap Down
OSRH
OSR
N/A$0.55
-3.6%
N/AN/A$12.41MN/A0.00N/A
FEMY
Femasys
3.0889 of 5 stars
$0.38
+2.4%
$7.33
+1,805.3%
-65.0%$12.24M$1.63M-0.4530Short Interest ↑
Gap Up
High Trading Volume
CODX
Co-Diagnostics
4.0593 of 5 stars
$0.31
+0.2%
$5.50
+1,671.9%
-74.0%$11.94M$3.91M-0.27100Short Interest ↑
Gap Up
MHUA
Meihua International Medical Technologies
1.6381 of 5 stars
$0.38
+2.2%
N/A-54.8%$11.81M$96.90M0.00620Positive News
Short Interest ↓
Gap Down
DHAI
DIH Holding US
N/A$0.22
-8.9%
N/A-91.3%$11.59M$64.47M-0.74N/AShort Interest ↑

Related Companies and Tools


This page (NASDAQ:NAOV) was last updated on 9/15/2025 by MarketBeat.com Staff
From Our Partners